Tyrosine Kinase Discoidin Domain Receptors DDR1 and DDR2 are Coordinately Deregulated in Triple Negative Breast Cancer

PURPOSE: Receptor kinases Discoidin Domain Receptors (DDRs) 1 and 2 are emerging as new therapeutic targets in breast cancer (BC). However, the expression of DDR proteins during BC progression and their association with BC subtypes remain poorly defined. Herein we report the first comprehensive immu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res Treat
Autori principali: Toy, Kathy A., Valiathan, Rajeshwari R., Núñez, Fernando, Kidwell, Kelley M., Gonzalez, Maria E., Fridman, Rafael, Kleer, Celina G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5058333/
https://ncbi.nlm.nih.gov/pubmed/25667101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-015-3285-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi